Cytos Biotechnology Ltd: CYT003-QbG10 phase IIb data presented at EAACI 2010 in London, UK

Schlieren, (PresseBox) - Cytos Biotechnology Ltd (SIX:CYTN) is pleased to inform you about two presentations at the 29th Congress of the European Academy of Allergy and Clinical Immunology in London, UK from June 5-9, 2010.

Prof. Klimek, the principal investigator of the study, will present 'Treatment with CYT003-QbG10, an allergenfree immunomodulator, reduces allergic symptoms in patients with rhinoconjunctivitis due to house dust mite allergy' on Sunday, June 6, 2010, 10.30 am - 12.00 pm.

Dr. Bachmann, CSO of Cyots Biotechnology, will present 'Bacteriophage coupled Fel d1 a novel immunotherapy agent for cat allergy' on Tuesday, June 8, 2010 at 10.30 am.

Press releases you might also be interested in

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.

I want to subscribe to the gratis press mail and have read and accepted the conditions.